Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian A Ference

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
European Heart Journal|October 12, 2017
How to use Mendelian randomization to anticipate the results of randomized trialsBrian A Ference
Current Opinion in Lipidology|January 19, 2016
Mendelian randomization studies: using naturally randomized genetic data to fill evidence gapsBrian A Ference
Cardiology Clinics|April 4, 2018
Causal Effect of Lipids and Lipoproteins on Atherosclerosis: Lessons from Genomic StudiesBrian A Ference
Clinical Pharmacology and Therapeutics|June 29, 2018
Using Genetic Variants in the Targets of Lipid Lowering Therapies to Inform Drug Discovery and Development: Current and Future Treatment OptionsBrian A Ference
JAMA|April 3, 2022
The Potential Clinical Benefit of Lowering Lipoprotein(a)Brian A Ference
Journal of the American College of Cardiology|August 11, 2022
Interpreting the Clinical Implications of Drug-Target Mendelian Randomization StudiesBrian A Ference
European Heart Journal|June 23, 2017
Vaccination to prevent atherosclerotic cardiovascular diseasesUlrich Laufs, Brian A Ference
Journal of the American College of Cardiology|August 29, 2015
Reply: Genetic Variation in NPC1L1 and Risk of Gallstone DiseaseBrian A Ference, Raju Penumetcha
Current Atherosclerosis Reports|February 21, 2013
The role of early LDL lowering to prevent the onset of atherosclerotic diseaseBrian A Ference, Nitin Mahajan
Journal of the American College of Cardiology|March 19, 2013
Reply: To PMID 23083789Brian A Ference, Nitin Mahajan
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
European Heart Journal|October 12, 2017
How to use Mendelian randomization to anticipate the results of randomized trialsBrian A Ference
Current Opinion in Lipidology|January 19, 2016
Mendelian randomization studies: using naturally randomized genetic data to fill evidence gapsBrian A Ference
Cardiology Clinics|April 4, 2018
Causal Effect of Lipids and Lipoproteins on Atherosclerosis: Lessons from Genomic StudiesBrian A Ference
Clinical Pharmacology and Therapeutics|June 29, 2018
Using Genetic Variants in the Targets of Lipid Lowering Therapies to Inform Drug Discovery and Development: Current and Future Treatment OptionsBrian A Ference
JAMA|April 3, 2022
The Potential Clinical Benefit of Lowering Lipoprotein(a)Brian A Ference
Journal of the American College of Cardiology|August 11, 2022
Interpreting the Clinical Implications of Drug-Target Mendelian Randomization StudiesBrian A Ference
European Heart Journal|June 23, 2017
Vaccination to prevent atherosclerotic cardiovascular diseasesUlrich Laufs, Brian A Ference
Journal of the American College of Cardiology|August 29, 2015
Reply: Genetic Variation in NPC1L1 and Risk of Gallstone DiseaseBrian A Ference, Raju Penumetcha
Current Atherosclerosis Reports|February 21, 2013
The role of early LDL lowering to prevent the onset of atherosclerotic diseaseBrian A Ference, Nitin Mahajan
Journal of the American College of Cardiology|March 19, 2013
Reply: To PMID 23083789Brian A Ference, Nitin Mahajan
Pageof 7